MEDICINOVA, INC. Share-based Payment Arrangement, Expense
MEDICINOVA, INC. (MNOV) reported Share-based Payment Arrangement, Expense of $176.77 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13
- MEDICINOVA, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $176.77K, a 13.73% decline year-over-year.
- MEDICINOVA, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $407.76K, a 42.60% increase year-over-year.
- MEDICINOVA, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $180.56K, a 31.60% decline year-over-year.
- MEDICINOVA, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $157.69K, a 68.77% decline year-over-year.
- MEDICINOVA, INC. share-based payment arrangement, expense for fiscal 2025 was $829.10K, a 30.43% decline from fiscal 2024.
- MEDICINOVA, INC. share-based payment arrangement, expense for fiscal 2024 was $1.19M, a 67.68% increase from fiscal 2023.
- MEDICINOVA, INC. share-based payment arrangement, expense for fiscal 2023 was $710.71K, a 10.61% increase from fiscal 2022.
- MEDICINOVA, INC. share-based payment arrangement, expense for fiscal 2022 was $642.52K, a 62.59% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $176.77K 10-Q · filed 2026-08-13 | $584.53K 10-Q · filed 2026-08-13 | $765.09K derived: sum of 3 quarters · filed 2026-08-13 | $922.78K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $407.76K 10-Q · filed 2026-05-14 | $588.32K derived: sum of 2 quarters · filed 2026-05-14 | $746.02K derived: sum of 3 quarters · filed 2026-05-14 | $950.91K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $180.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $338.25K derived: sum of 2 quarters · filed 2026-03-10 | $543.15K derived: sum of 3 quarters · filed 2026-08-13 | $829.10K 10-K · filed 2026-03-10 |
| 2025-09-30 | $157.69K 10-Q · filed 2025-11-12 | $362.59K derived: sum of 2 quarters · filed 2026-08-13 | $648.53K 10-Q · filed 2025-11-12 | $912.52K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $204.90K 10-Q · filed 2026-08-13 | $490.84K 10-Q · filed 2026-08-13 | $754.83K derived: sum of 3 quarters · filed 2026-08-13 | $1.26M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $285.94K 10-Q · filed 2026-05-14 | $549.94K derived: sum of 2 quarters · filed 2026-05-14 | $1.05M derived: sum of 3 quarters · filed 2026-05-14 | $1.26M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $263.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $768.86K derived: sum of 2 quarters · filed 2026-03-10 | $976.31K derived: sum of 3 quarters · filed 2026-03-10 | $1.19M 10-K · filed 2026-03-10 |
| 2024-09-30 | $504.86K 10-Q · filed 2025-11-12 | $712.32K derived: sum of 2 quarters · filed 2025-11-12 | $927.75K 10-Q · filed 2025-11-12 | $690.34K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $207.46K 10-Q · filed 2025-08-14 | $422.88K 10-Q · filed 2025-08-14 | $185.48K derived: sum of 3 quarters · filed 2025-08-14 | $404.62K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $215.43K 10-Q · filed 2025-05-13 | -$21.98K derived: sum of 2 quarters · filed 2025-05-13 | $197.17K derived: sum of 3 quarters · filed 2025-05-13 | $522.88K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$237.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$18.26K derived: sum of 2 quarters · filed 2025-02-19 | $307.45K derived: sum of 3 quarters · filed 2025-02-19 | $710.71K 10-K · filed 2025-02-19 |
| 2023-09-30 | $219.14K 10-Q · filed 2024-11-13 | $544.85K derived: sum of 2 quarters · filed 2024-11-13 | $948.12K 10-Q · filed 2024-11-13 | $1.08M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $325.71K 10-Q · filed 2024-08-08 | $728.97K 10-Q · filed 2024-08-08 | $857.64K derived: sum of 3 quarters · filed 2024-08-08 | $1.02M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $403.26K 10-Q · filed 2024-05-09 | $531.93K derived: sum of 2 quarters · filed 2024-05-09 | $690.23K derived: sum of 3 quarters · filed 2024-05-09 | $964.73K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $128.67K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $286.97K derived: sum of 2 quarters · filed 2024-02-15 | $561.47K derived: sum of 3 quarters · filed 2024-02-15 | $642.52K 10-K · filed 2024-02-15 |
| 2022-09-30 | $158.30K 10-Q · filed 2023-11-09 | $432.80K derived: sum of 2 quarters · filed 2023-11-09 | $513.85K 10-Q · filed 2023-11-09 | -$243.12K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $274.50K 10-Q · filed 2023-08-09 | $355.56K 10-Q · filed 2023-08-09 | -$401.42K derived: sum of 3 quarters · filed 2023-08-09 | $177.53K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $81.05K 10-Q · filed 2023-05-11 | -$675.92K derived: sum of 2 quarters · filed 2023-05-11 | -$96.97K derived: sum of 3 quarters · filed 2023-05-11 | $658.93K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$756.97K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | -$178.03K derived: sum of 2 quarters · filed 2023-03-28 | $577.88K derived: sum of 3 quarters · filed 2023-03-28 | $1.72M 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $578.94K 10-Q · filed 2022-11-10 | $1.33M derived: sum of 2 quarters · filed 2022-11-10 | $2.47M 10-Q · filed 2022-11-10 | $2.87M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $755.90K 10-Q · filed 2022-08-11 | $1.90M 10-Q · filed 2022-08-11 | $2.29M derived: sum of 3 quarters · filed 2022-08-11 | $3.33M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.14M 10-Q · filed 2022-05-12 | $1.54M derived: sum of 2 quarters · filed 2022-05-12 | $2.57M derived: sum of 3 quarters · filed 2022-05-12 | $3.72M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $398.05K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $1.43M derived: sum of 2 quarters · filed 2022-02-16 | $2.58M derived: sum of 3 quarters · filed 2022-02-16 | $3.18M 10-K · filed 2022-02-16 |
| 2020-09-30 | $1.03M 10-Q · filed 2021-11-12 | $2.18M derived: sum of 2 quarters · filed 2021-11-12 | $2.78M 10-Q · filed 2021-11-12 | $1.97M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $1.15M 10-Q · filed 2021-08-12 | $1.74M 10-Q · filed 2021-08-12 | $940.32K derived: sum of 3 quarters · filed 2021-08-12 | $1.31M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $596.38K 10-Q · filed 2021-05-13 | -$206.83K derived: sum of 2 quarters · filed 2021-05-13 | $167.01K derived: sum of 3 quarters · filed 2021-05-13 | $2.01M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$803.21K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$429.37K derived: sum of 2 quarters · filed 2021-02-19 | $1.41M derived: sum of 3 quarters · filed 2021-02-19 | $4.11M 10-K · filed 2021-02-19 |
| 2019-09-30 | $373.84K 10-Q · filed 2020-10-26 | $2.22M derived: sum of 2 quarters · filed 2020-10-26 | $4.92M 10-Q · filed 2020-10-26 | $3.16M derived: sum of 4 quarters · filed 2020-10-26 |
| 2019-06-30 | $1.84M 10-Q · filed 2020-07-28 | $4.54M 10-Q · filed 2020-07-28 | $2.79M derived: sum of 3 quarters · filed 2020-07-28 | $7.52M derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-03-31 | $2.70M 10-Q · filed 2020-04-23 | $947.91K derived: sum of 2 quarters · filed 2020-04-23 | $5.68M derived: sum of 3 quarters · filed 2020-04-23 | $6.50M derived: sum of 4 quarters · filed 2020-04-23 |
| 2018-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $2.98M derived: sum of 2 quarters · filed 2020-02-13 | $3.80M derived: sum of 3 quarters · filed 2020-02-13 | $6.33M 10-K · filed 2020-02-13 |
| 2018-09-30 | $4.73M 10-Q · filed 2019-10-24 | $5.55M derived: sum of 2 quarters · filed 2019-10-24 | $8.08M 10-Q · filed 2019-10-24 | |
| 2018-06-30 | $823.21K 10-Q · filed 2019-07-25 | $3.35M 10-Q · filed 2019-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |